|
1.
|
Bruera E and Kim HN: Cancer pain. JAMA.
290:2476–2479. 2003. View Article : Google Scholar
|
|
2.
|
Serlin RC, Mendoza TR, Nakamura Y, Edwards
KR and Cleeland CS: When is cancer pain mild, moderate or severe?
Grading pain severity by its interference with function. Pain.
61:277–284. 1995. View Article : Google Scholar
|
|
3.
|
Reid CM, Martin RM, Sterne JA, Davies AN
and Hanks GW: Oxycodone for cancer-related pain: meta-analysis of
randomized controlled trials. Arch Intern Med. 166:837–843. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Breivik H, Cherny N, Collett B, de Conno
F, Filbet M, Foubert AJ, Cohen R and Dow L: Cancer-related pain: a
pan-European survey of prevalence, treatment, and patient
attitudes. Ann Oncol. 20:1420–1433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Gomes T, Juurlink DN, Dhalla IA,
Mailis-Gagnon A, Paterson JM and Mamdani M: Trends in opioid use
and dosing in the socioeconomically disadvantaged. Open Med.
5:E13–E22. 2011.
|
|
6.
|
Garcia del Pozo J, Carvajal A, Viloria JM,
Velasco A and Garcia del Pozo V: Trends in the consumption of
opioid analgesics in Spain. Higher increases as fentanyl replaces
morphine. Eur J Clin Pharmacol. 64:411–415. 2008.PubMed/NCBI
|
|
7.
|
Jost L and Roila F; ESMO Guidelines
Working Group: Management of cancer pain: ESMO Clinical Practice
Guidelines. Ann Oncol. (Suppl 5): v257–v260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Panchal SJ, Müller-Schwefe P and
Wurzelmann JI: Opioid-induced bowel dysfunction: prevalence,
pathophysiology and burden. Int J Clin Pract. 61:1181–1187. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Paulozzi LJ and Ryan GW: Opioid analgesics
and rates of fatal drug poisoning in the United States. Am J Prev
Med. 31:506–511. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Boudreau D, Von Korff M, Rutter CM,
Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO,
Silverberg MJ, Banta-Green C and Weisner C: Trends in long-term
opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug
Saf. 18:1166–1175. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jadad AR, Moore RA, Carroll D, Jenkinson
C, Reynolds DJ, Gavaghan DJ and McQuay HJ: Assessing the quality of
reports of randomized clinical trials: is blinding necessary?
Control Clin Trials. 17:1–12. 1996. View Article : Google Scholar
|
|
12.
|
Lubin JH and Gail MH: Biased selection of
controls for case-control analyses of cohort studies. Biometrics.
40:63–75. 1984. View
Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kjaergard LL, Villumsen J and Gluud C:
Reported methodologic quality and discrepancies between large and
small randomized trials in meta-analyses. Ann Intern Med.
135:982–989. 2001. View Article : Google Scholar
|
|
14.
|
Guyatt G, Gutterman D, Baumann MH,
Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ and
Schünemann H: Grading strength of recommendations and quality of
evidence in clinical guidelines: Report from an american college of
chest physicians task force. Chest. 129:174–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Park-Wyllie LY, Mamdani MM, Li P, Gill SS,
Laupacis A and Juurlink DN: Cholinesterase inhibitors and
hospitalization for bradycardia: a population-based study. PLoS
Med. 6:e10001572009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Charlson ME, Pompei P, Ales KL and
MacKenzie CR: A new method of classifying prognostic comorbidity in
longitudinal studies: development and validation. J Chronic Dis.
40:373–383. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Mamdani M, Sykora K, Li P, Normand SL,
Streiner DL, Austin PC, Rochon PA and Anderson GM: Reader’s guide
to critical appraisal of cohort studies: 2. Assessing potential for
confounding. BMJ. 330:960–962. 2005.
|
|
18.
|
Li SY, Shang ZZ and Xue G: Clinical
efficacy of oxycodone hydrochloride controlled-release tablets for
cancer pain. Shanxi Oncol Med. 10:16–18. 2002.
|
|
19.
|
Yu XH, Wu DG, Yang JF and Gao M: Clinical
efficacy of oxycodone hydrochloride controlled-release tablets in
management of moderate and severe cancer pain. Chin J Hosp Pharm.
27:1277–1278. 2007.
|
|
20.
|
Shi L, Xiong HH, Yang L and Yu SY:
Analgesic effect of oxycodone-acetaminophen tablets in patients
with cervical cancer. Chin J New Drugs. 17:1884–1885. 2008.
|
|
21.
|
Wang P, Liu Y, Wang T and Chen BZ: The
observation of curative effect of oxycodone hydrochloride
controlled-release fablets in management of moderate and severe
cancer pain. Mod Oncol. 16:1983–1985. 2008.
|
|
22.
|
Xiong J, Liang C, Wu X, Zhao YX, Fu L and
Zhou YF: Efficacy and safety of oxycodone-acetaminophen tablet in
142 patients with different types of moderate and advanced cancer
pain. Chin J New Drugs. 17:1877–1900. 2008.
|
|
23.
|
Hou EC and Wang X: Clinical efficacy of
oxycodone-acetaminophen tablet in management of cancer pain and its
effect on immune function. J Guangxi Med Univ. 26:446–448.
2009.
|
|
24.
|
Huang SW, Xie YF and Dong J: The
observation of clinical eficacy of oxycodone-acetaminophen tablet
in management of digestive cancer pain. Mod J Integr Tradit Chin
West Med. 19:2628–2629. 2010.
|
|
25.
|
Riley J, Eisenberg E, Müller-Schwefe G,
Drewes AM and Arendt-Nielsen L: Oxycodone: a review of its use in
the management of pain. Curr Med Res Opin. 24:175–192. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
King SJ, Reid C, Forbes K and Hanks G: A
systematic review of oxycodone in the management of cancer pain.
Palliat Med. 25:454–470. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Pan H, Zhang Z, Zhang Y, Xu N, Lu L, Dou
C, Guo Y, Wu S, Yue J, Wu D and Dai Y: Efficacy and tolerability of
oxycodone hydrochloride controlled-release tablets in moderate to
severe cancer pain. Clin Drug Investig. 27:259–267. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Ordóñez Gallego A, González Barón M and
Espinosa Arranz E: Oxycodone: a pharmacological and clinical
review. Clin Transl Oncol. 9:298–307. 2007.
|
|
29.
|
Eisenberg E, McNicol ED and Carr DB:
Efficacy and safety of opioid agonists in the treatment of
neuropathic pain of nonmalignant origin: systematic review and
meta-analysis of randomized controlled trials. JAMA. 293:3043–3052.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Leppert W: Role of oxycodone and
oxycodone/naloxone in cancer pain management. Pharmacol Rep.
62:578–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
